Schedule 13G ownership disclosure

Halozyme Therapeutics Inc

COMMON STOCK · CUSIP: 40637H109

Event date: 2025-03-31

Filing-level shares
6,053,007.00
Percent of class
4.9%
  • STATE STREET CORPORATION

    Shares: 6,053,007.00 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-25-000277
Form type
SCHEDULE 13G
Filer
HALOZYME THERAPEUTICS, INC.
CIK
CIK 1159036
Filed
May 13, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub